Mereo BioPharma Group plc

SEC 4 · Filed

0001193125-26-033754Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 1, 2026

Grant, award or other acquisition by Lewicki John A.

Security
Share Options (Right to buy)
Code
A
Shares
145,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-01",
  "direction": "A",
  "exercise_price": "0.44",
  "expiration": "2036-02-01",
  "footnotes": {
    "F2": "Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.",
    "F3": "Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date."
  },
  "owners": [
    {
      "cik": "0001553352",
      "name": "Lewicki John A.",
      "roles": [
        "officer"
      ],
      "title": "Chief Scientific Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "145000",
  "price": "0.00",
  "row": 3,
  "rule_10b5_1": "false",
  "security": "Share Options (Right to buy)",
  "shares": "145000",
  "table": "II",
  "underlying_security": "American Depository Shares",
  "underlying_shares": "145000"
}
Insider transactionsEvent date Feb 1, 2026

Grant, award or other acquisition by Lewicki John A.

Security
Share Options (Right to buy)
Code
A
Shares
46,637
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-01",
  "direction": "A",
  "exercise_price": "1.00",
  "expiration": "2036-02-01",
  "footnotes": {
    "F1": "25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.",
    "F2": "Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."
  },
  "owners": [
    {
      "cik": "0001553352",
      "name": "Lewicki John A.",
      "roles": [
        "officer"
      ],
      "title": "Chief Scientific Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "46637",
  "price": "0.00",
  "row": 2,
  "rule_10b5_1": "false",
  "security": "Share Options (Right to buy)",
  "shares": "46637",
  "table": "II",
  "underlying_security": "American Depository Shares",
  "underlying_shares": "46637"
}
Insider transactionsEvent date Feb 1, 2026

Grant, award or other acquisition by Lewicki John A.

Security
Share Options (Right to buy)
Code
A
Shares
139,913
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-01",
  "direction": "A",
  "exercise_price": "0.44",
  "expiration": "2036-02-01",
  "footnotes": {
    "F1": "25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.",
    "F2": "Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."
  },
  "owners": [
    {
      "cik": "0001553352",
      "name": "Lewicki John A.",
      "roles": [
        "officer"
      ],
      "title": "Chief Scientific Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "139913",
  "price": "0.00",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Share Options (Right to buy)",
  "shares": "139913",
  "table": "II",
  "underlying_security": "American Depositary Shares",
  "underlying_shares": "139913"
}